Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-068046
Filing Date
2025-05-09
Accepted
2025-05-09 16:16:38
Documents
68
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q srzn-20250331.htm   iXBRL 10-Q 2338929
2 EX-31.1 srzn-ex31_1.htm EX-31.1 17071
3 EX-31.2 srzn-ex31_2.htm EX-31.2 17130
4 EX-32.1 srzn-ex32_1.htm EX-32.1 9662
5 EX-32.2 srzn-ex32_2.htm EX-32.2 9700
6 GRAPHIC img201622236_0.jpg GRAPHIC 55182
  Complete submission text file 0000950170-25-068046.txt   9870477

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT srzn-20250331.xsd EX-101.SCH 1527001
71 EXTRACTED XBRL INSTANCE DOCUMENT srzn-20250331_htm.xml XML 1699694
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Filer) CIK: 0001824893 (see all company filings)

EIN.: 301374889 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39635 | Film No.: 25930657
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)